GSK has received FDA approval for Blenrep (belantamab mafodotin-blmf) with bortezomib and dexamethasone to treat adults with relapsed or refractory multiple myeloma after at least two prior therapies...
Zotefoams has appointed Jack Clarke as an independent Non-Executive Director effective 28 October 2025. Clarke, formerly CFO of Essentra and Marshalls, brings extensive strategy and finance experience and will join the Audit, Nomination and Remuneration Committees...
Record plc has reported a new high in assets under management of $110.3bn for the quarter ended 30 September 2025, supported by positive asset growth and inflows into its Solutions for Asset Managers and FX Alpha strategies...
Touchstone Exploration has conditionally raised £6.32 million through a private placement of 57.5 million new shares at 11 pence each. The Company may raise an additional £0.68 million via a retail offer to existing shareholders...
Earl Anderson joins Physicians Capital as Strategic Advisor, bringing 40+ years of leadership in orthopaedics to support physician ownership and investment growth...
GSK has received FDA approval for Blenrep (belantamab mafodotin-blmf) with bortezomib and dexamethasone to treat adults with relapsed or refractory multiple myeloma after at least two prior therapies...
Zotefoams has appointed Jack Clarke as an independent Non-Executive Director effective 28 October 2025. Clarke, formerly CFO of Essentra and Marshalls, brings extensive strategy and finance experience and will join the Audit, Nomination and Remuneration Committees...
Record plc has reported a new high in assets under management of $110.3bn for the quarter ended 30 September 2025, supported by positive asset growth and inflows into its Solutions for Asset Managers and FX Alpha strategies...
Touchstone Exploration has conditionally raised £6.32 million through a private placement of 57.5 million new shares at 11 pence each. The Company may raise an additional £0.68 million via a retail offer to existing shareholders...
Earl Anderson joins Physicians Capital as Strategic Advisor, bringing 40+ years of leadership in orthopaedics to support physician ownership and investment growth...
